Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort

BMC Infectious Diseases

Research

Marie Méan¹  Onya Opota²  Valentin Scherz²  Claire Bertelli²  Yangji Choi²  Gilbert Greub²  Tatiana Galperine³  Matthaios Papadimitriou-Olivgeris³  Benoit Guery³  Antonios Kritikos⁴  Jean-Luc Pagani⁵ 

[1] Division of Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland;Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland;Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, BH10-553, 1011, Lausanne, Switzerland;Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, BH10-553, 1011, Lausanne, Switzerland;Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland;Service of Intensive Care, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland;

关键词: COVID-19;    SARS-CoV-2;    Gut microbiota;    Microbiota profiling;    Gut-lung axis;   

DOI  :  10.1186/s12879-023-08511-6

 received in 2023-04-04, accepted in 2023-08-04,  发布年份 2023

来源: Springer

【 摘 要 】

BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a multifaceted disease potentially responsible for various clinical manifestations including gastro-intestinal symptoms. Several evidences suggest that the intestine is a critical site of immune cell development, gut microbiota could therefore play a key role in lung immune response. We designed a monocentric longitudinal observational study to describe the gut microbiota profile in COVID-19 patients and compare it to a pre-existing cohort of ventilated non-COVID-19 patients.MethodsFrom March to December 2020, we included patients admitted for COVID-19 in medicine (43 not ventilated) or intensive care unit (ICU) (14 ventilated) with a positive SARS-CoV-2 RT-PCR assay in a respiratory tract sample. 16S metagenomics was performed on rectal swabs from these 57 COVID-19 patients, 35 with one and 22 with multiple stool collections. Nineteen non-COVID-19 ICU controls were also enrolled, among which 14 developed ventilator-associated pneumonia (pneumonia group) and five remained without infection (control group). SARS-CoV-2 viral loads in fecal samples were measured by qPCR.ResultsAlthough similar at inclusion, Shannon alpha diversity appeared significantly lower in COVID-19 and pneumonia groups than in the control group at day 7. Furthermore, the microbiota composition became distinct between COVID-19 and non-COVID-19 groups. The fecal microbiota of COVID-19 patients was characterized by increased Bacteroides and the pneumonia group by Prevotella. In a distance-based redundancy analysis, only COVID-19 presented significant effects on the microbiota composition. Moreover, patients in ICU harbored increased Campylobacter and decreased butyrate-producing bacteria, such as Lachnospiraceae, Roseburia and Faecalibacterium as compared to patients in medicine. Both the stay in ICU and patient were significant factors affecting the microbiota composition. SARS-CoV-2 viral loads were higher in ICU than in non-ICU patients.ConclusionsOverall, we identified distinct characteristics of the gut microbiota in COVID-19 patients compared to control groups. COVID-19 patients were primarily characterized by increased Bacteroides and decreased Prevotella. Moreover, disease severity showed a negative correlation with butyrate-producing bacteria. These features could offer valuable insights into potential targets for modulating the host response through the microbiota and contribute to a better understanding of the disease's pathophysiology.Trial registrationCER-VD 2020–00755 (05.05.2020) & 2017–01820 (08.06.2018).

【 授权许可】

CC BY   
© BioMed Central Ltd., part of Springer Nature 2023

【 图 表 】

40517_2023_266_Article_IEq62.gif

40517_2023_266_Article_IEq58.gif

40517_2023_266_Article_IEq48.gif

40517_2023_266_Article_IEq45.gif

40517_2023_266_Article_IEq34.gif